Vaccine response registry for immune-weakened patients
Part of Immune system & allergy clinical trials.
This study creates a registry to track how people with weakened immune systems respond to vaccines. It helps doctors better understand which vaccines work best for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a weakened immune system now or will soon (for example, from illness or treatment).
- You (or your parent/guardian) can sign a consent form to participate.
- You can understand and follow the study rules (like attending visits).
- You do not have serious language problems, mental health issues, or substance abuse that would make participation hard.
- You do not plan to leave the country or miss more than 2 months in the next 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study collects blood and tissue samples from patients with rare immune system diseases that started in childhood, and from their relatives and healthy volunteers. The goal is to build a biocollection for future research to better understand these diseases.
This study looks at how well vaccines for respiratory viruses work in people with weakened immune systems. It may help doctors give better vaccine advice to patients like you.
This study is a registry that collects health information and monitors people with immune-mediated inflammatory diseases. By joining, you help researchers follow the course of these conditions and improve care.
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
This study is for adults whose immune system has trouble fighting viruses due to specific antibodies or a genetic condition. Researchers want to follow these people over time to better understand the condition and improve care.
Hear when a new Immunosuppression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.